Language Scientific Receives Second Patent for Prescription Translation Verification Technology
The U.S. Patent and Trademark Office has granted Language Scientific a second patent for its RxTran technology. This technology allows pharmacists to verify translations they cannot read.
Language Scientific has secured a second U.S. patent for its RxTran technology, which enables pharmacists to verify prescription translations they cannot read.
The new patent extends the technology's application beyond pharmacy labels to hospital discharge and emergency instructions. This near-real-time verification process is crucial for medical safety, particularly in multilingual settings.
The technology aims to address language translation challenges in healthcare, reducing the risk of errors and enhancing patient safety. It provides a means to ensure patients accurately understand medical instructions, regardless of their native language or the staff's linguistic capabilities.
Language Scientific stated that this development strengthens its position as a provider of healthcare translation solutions. The company continues to invest in the technology's advancement.